Combination of Recombinant Proteins S1/N and RBD/N as Potential Vaccine Candidates

Despite all successful efforts to develop a COVID-19 vaccine, the need to evaluate alternative antigens to produce next-generation vaccines is imperative to target emerging variants. Thus, the second generation of COVID-19 vaccines employ more than one antigen from severe acute respiratory syndrome...

Cijeli opis

Bibliografski detalji

Glavni autori:	Noe Juvenal Mendoza-Ramírez, Julio García-Cordero, Sandra Paola Martínez-Frías, Daniela Roa-Velázquez, Rosendo Luria-Pérez, José Bustos-Arriaga, Jesús Hernández-Lopez, Carlos Cabello-Gutiérrez, Joaquín Alejandro Zúñiga-Ramos, Edgar Morales-Ríos, Sonia Mayra Pérez-Tapia, Martha Espinosa-Cantellano, Leticia Cedillo-Barrón
Format:	Artigo
Jezik:	Inglês
Izdano:	MDPI AG 2023-04-01
Serija:	Vaccines
Teme:	SARS-CoV-2 vaccine nucleocapsid protein spike protein RBD domain
Online pristup:	https://www.mdpi.com/2076-393X/11/4/864
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!